Bladder Botox denied for failing step therapy by Humana?

Humana's specific coverage criteria for bladder botox are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.

## Why Humana Requires Step Therapy Before Bladder Botox — and How to Appeal

Step therapy (also called "fail-first") is among the most common reasons Humana denies bladder Botox on first submission. Humana's coverage policy typically requires documentation that a patient has tried and had an inadequate response to — or cannot tolerate — one or more oral overactive bladder medications before bladder Botox will be authorized. The denial does not mean Botox is inappropriate; it means Humana wants proof that the required prior steps actually happened.

Many of these denials are reversible on appeal because patients often have already completed the required steps — the documentation simply was not submitted with the original request, or the prescriber's notes did not use the specific language the policy requires.

## Your Federal Appeal Rights

ACA §2719 guarantees internal appeal and external review rights for non-grandfathered plans. ERISA §503 provides the same for employer-sponsored plans. You have up to 180 days from the denial notice to initiate an internal appeal. If the plan upholds the denial, you may request binding external review by an Independent Review Organization (IRO) — generally within four months of the final internal decision. An expedited pathway exists when your condition is urgent and the standard timeline would seriously jeopardize your health.

Several states also have step-therapy override laws that require insurers to grant exceptions when the required step therapies are contraindicated, previously failed, or clinically inappropriate for the individual patient. Check whether your state's law applies to your plan.

## Documentation to Gather

• Prior medication trial records: For every oral agent the policy requires, document the drug name, start date, stop date, dose adjustments (per the chart — do not fabricate specifics), reason for discontinuation, and the treating provider's clinical assessment. Pharmacy claims records can supplement chart notes.
• Intolerance or contraindication documentation: If any required step therapy was not completed because of a documented intolerance or clinical reason, include the prescriber's chart note or letter explaining this.
• Severity and functional impact: Chart notes describing the degree of urinary incontinence or urgency, its impact on daily activities, and why earlier-line options were exhausted or inappropriate.
• Prescriber letter: A letter that walks through each step in Humana's policy and explicitly maps it to a documented chart event — trial attempted, outcome, clinical rationale for proceeding to Botox.
• Humana's step-therapy policy: Download the current version from Humana's portal and ensure your appeal addresses every listed step.

## Criteria-Mapping Structure

Create a table with a row for each required step in Humana's policy. Columns: requirement as written in policy | drug/therapy tried | start date | stop date | outcome/reason stopped | source document. Submit this table as the first page of your appeal letter so the reviewer can verify compliance at a glance.